Applied Current Deferred Revenue from 2010 to 2026
| BNBX Stock | 1.36 0.12 8.11% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 52.9 K | Current Value 50.3 K | Quarterly Volatility 133.6 K |
Check Applied DNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied DNA's main balance sheet or income statement drivers, such as Net Interest Income of 232.9 K, Interest Income of 232.9 K or Depreciation And Amortization of 838.7 K, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.0424. Applied financial statements analysis is a perfect complement when working with Applied DNA Valuation or Volatility modules.
Applied | Current Deferred Revenue | Build AI portfolio with Applied Stock |
Latest Applied DNA's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Applied DNA Sciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Applied DNA's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied DNA's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Applied Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 232,455 | |
| Geometric Mean | 184,784 | |
| Coefficient Of Variation | 57.48 | |
| Mean Deviation | 101,777 | |
| Median | 281,000 | |
| Standard Deviation | 133,615 | |
| Sample Variance | 17.9B | |
| Range | 513.3K | |
| R-Value | (0.54) | |
| Mean Square Error | 13.4B | |
| R-Squared | 0.29 | |
| Significance | 0.02 | |
| Slope | (14,357) | |
| Total Sum of Squares | 285.6B |
Applied Current Deferred Revenue History
About Applied DNA Financial Statements
Applied DNA investors use historical fundamental indicators, such as Applied DNA's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Applied DNA. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 52.9 K | 50.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Applied Stock Analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.